Advanced Biomed Inc. (ADVB) vs T2 Biosystems, Inc. (TTOO)

Advanced Biomed Inc. and T2 Biosystems, Inc. are both Diagnostics & Research companies. Advanced Biomed Inc. is the larger, with a market value of $8.1M against $6.5M — 1.2× the size. T2 Biosystems, Inc. has negative trailing earnings, so its P/E is not meaningful; Advanced Biomed Inc. trades at 0.8×. Advanced Biomed Inc. has the higher net margin (0.00% vs −559.5%) and the lower return on invested capital (−33.4% vs 0.00%). Across the 11 metrics below, Advanced Biomed Inc. leads on 8 and T2 Biosystems, Inc. on 3.

Valuation

Metric ADVB TTOO Diagnostics & Research median
P/E 0.77 n/m 35.56
P/S n/m n/m 4.37
P/B 0.41 n/m 3.06
Price to free cash flow n/m n/m 35.76
EV/EBITDA n/m n/m 24.35
EV/Sales n/m 6.26 5.51
Earnings yield 129.37% 0.00% (1.89%)
Free cash flow yield (90.81%) 0.00% (0.15%)

Profitability

Metric ADVB TTOO Diagnostics & Research median
Gross margin — (76.76%) 50.89%
Operating margin 0.00% (542.59%) (8.57%)
Net margin 0.00% (559.52%) (6.37%)
Free cash flow margin 0.00% (476.64%) 0.00%
Return on equity 84.77% 277.61% (2.92%)
Return on assets 36.47% (140.00%) (6.71%)
Return on invested capital (33.43%) 0.00% 0.00%

Growth

Metric ADVB TTOO Diagnostics & Research median
Revenue growth (TTM) — (30.19%) 7.69%
EPS growth (last fiscal year) 266.53% 98.44% 25.92%
Revenue growth, 5-year CAGR — (7.29%) 7.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ADVB TTOO Diagnostics & Research median
Debt to equity 0.00 0.00 0.11
Current ratio 9.33 0.40 2.02
Net debt to EBITDA 0.06 0.32 0.70

Dividend

Metric ADVB TTOO Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric ADVB TTOO Diagnostics & Research median
Market cap 8.06m 6.48m 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack